MYGN
Myriad Genetics Inc
4.60$
+0.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -26.1% | +18.4% | -36.1% | +9.1% | -27.8% | +0.0% | -77.8% | -671.5% | – | – | – | |
| – | +81.2% | +7.2% | +80.2% | +12.6% | +34.2% | +0.0% | -14.0% | -16.1% | +17.5% | -1.1% | -12.3% | |
| – | +68.6% | -30.9% | -5.4% | -9.4% | +23.6% | +0.0% | +8.4% | +5.0% | +6.8% | +22.4% | -29.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +51.8% | -563.5% | – | – | -169.1% | – | -301.5% | – | |
| – | +67.1% | -79.1% | +22.0% | +37.7% | +2.4% | +0.0% | +109.3% | +151.7% | +61.8% | -59.5% | -7.7% | |
| – | – | -323.5% | +60.1% | -92.1% | +2,369.0% | – | +1,321.8% | -128.2% | – | -137.3% | +130.3% | |
| – | – | – | – | – | – | +0.0% | – | – | – | – | – | |
| – | -26.8% | -22.8% | -80.6% | – | – | +0.0% | -100.0% | – | – | – | – | |
| – | – | – | – | – | – | – | – | -100.0% | – | -99.7% | +84,200.0% | |
| – | -16.3% | -61.5% | – | -232.3% | – | +0.0% | -182.6% | -94.7% | – | -104.8% | – | |
| – | – | – | +670.5% | -74.9% | -308.2% | – | – | -235.7% | – | -138.9% | – | |
| – | -33.7% | +38.3% | -37.9% | +7.4% | -30.1% | +0.0% | -99.2% | -25,366.7% | – | – | – |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.